“Yeah, the chemo industry really don’t like alternatives to its model. It’s tragic really. Here in the UK, chemo is the only option, unless you can get on a clinical trial (very difficult). And despite the fact that immunotherapy is so promising. The disease will ultimately kill me. But it won’t do it on its own it will be also down to lack of provision of cutting edge treatment”

(Andy P. 1975-2022, UK)
May his soul rest in peace.

Cancer

According to the World Health Organization, cancer causes around 10 million deaths per year. Cancer is the second leading cause of death in the United States, according to the CDC, with over 600,000 cancer deaths annually.

The most common forms of cancer are breast, lung, colon/rectum, and prostate.

The good news is that cancer can often be cured if it is detected early and treated properly.

As of early 2022, eighty percent of the world’s adults aged 65 and over have at least one chronic disease.
Our work at Novel Concepts Medical is about improving what science calls “healthspan,” or the number of years that people can live well without disease.
Our results clearly show that this mission is possible. With your support to our self-funded start-up, together we can make it happen faster.

Cancer Patients

Our research has found an important connection between the treatment of two different diseases, which may lead to a big step forward in the cure of cancer in the 21st century.

We found that there is a connection between the treatment disarming the COVID-19 spike protein and the treatment of cancer cells. Accordingly, we started early compassion treatment of cancer patients.

Skin Cancer Case Study

[A] One of our formulas was used as the exclusive treatment for a cancer patient with invasive squamous cell carcinoma being treated at Ichilov Hospital. Prior to starting the treatment, he had been diagnosed with basal cell carcinoma and invasive squamous cell carcinoma.

Following a few weeks of using our treatment, in January 2021 doctors at Ichilov Hospital confirmed that the patient’s ultrasound and CT scans came back negative with no metastasis.

Here are the photos of the volunteer patient before and after

Credit: Yankale Mazare

[B] In two other cases in which our formula was given to cancer patients, the patients saw reduction in metastasis within the first two weeks. This was observed on their CT scans and ultrasounds. One of these cases arrived to us after the doctors already told the family that it was her last day. We helped her open her eyes and talk with the family

for a few weeks longer. However, an overdose of morphine given by the doctors has terminated her life earlier than we would have expected based on the U.S. reports.

Colon Cancer - A Volunteer's Words

“I am confident that formula is helping. I know my body and how it reacts, and I know when the cancer is active or not. Since the drops, I have felt much better, and much less beset by tumor pain, which means less activity.”

Case Study Report: Improvement in Colon Cancer with Liver Metastasis

LONDON, United Kingdom — Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment. No side effects have been reported of our treatment.

It is known that approximately half of patients with colorectal cancer, which includes colon cancer, in the world develop metastases, and survival rates drop significantly among such patients.

This case study, as well as several others we performed, shows that plant-based treatment may improve the medical condition of cancer patients.

[A] History

A 46-year-old British patient was diagnosed with metastatic colon cancer with three liver metastases at the Royal Marsden hospital in London in July 2021.

Below is his diagnostic imaging report from 15 July 2021.

The following are the patient’s blood test results before our treatment, from 8 July 2021 to 15 November 2021:

[B] Our Treatment of the Patient

The patient exclusively received our plant-based treatment for a couple of weeks in July 2022 during a break between chemotherapy sessions, from 5 July 2022 through 20 July 2022.
Following that time, his blood tests confirmed that his liver biomarkers and blood test results improved and that his CEA cancer marker and C-reactive protein (CRP) decreased. These results show that the cancer shrank and that the inflammation level of the body significantly improved. His inflammation (CRP biomarkers) more than halved.
Our treatment also positively affected his appetite and energy. He was able to eat better, walk out of bed, and take a daily walk of a few miles during that period.
The following are the relevant changes to his biomarkers (the full results of his blood tests can be viewed in the photo of the blood test reports below):

Biomarker (unit)	Normal Range	05/07/2022 (before treatment)	20/07/2022 (after treatment)
Liver Biomarkers
Creatinine (μmol/L)	62-106	47	54
Albumin (g/L)	35-50	44	46
Alkaline phosphatase (iu/L)	30-130	83	86
Bilirubin (μmol/L)	<21	7	9
Total protein (g/L)	60-80	64	68
Globulin (g/L)	20-40	20	22
Other Biomarkers
Haemoglobin (g/L)	130-170	125	142
Lymphocytes (×10^9/L)	1.0-3.0	0.7	0.8
Haematocrit (L/L)	0.400-0.500	0.388	0.437
RBC (×10^12/L)	4.5-5.5	3.9	4.5
Creatinine (μmol/L)	62-106	47	54
C Reactive Protein	<5.0	10.8	4.3
(HCA) – CEA (ng/mL)	<3.9	14	13

After the period of our treatment and after an exam on October 6, 2022, his medical report concluded, “Overall essentially stable disease when compared to the previous CT . . . with a marginal reduction in the size of the enlarged left supraclavicular node and left adrenal metastatic deposit. Stable disease elsewhere.”
On 1 September 2022, the patient emailed, “Ok, so a bit of an update. I got the MRI results back and they were not as bad as we feared. Basically, the MRI confirms that there has been little change in the liver since this time last year, which is good news really.”

[C] The Patient’s Blood Tests Before and After Our Treatment

To conclude, this case study shows that Novel Concepts Medical’s plant-based, patent-pending treatments may significantly improve the medical results of colon cancer with liver metastases and halt the progress of tumors in the liver, in a noninvasive method.

The company plans to sell the plant-based treatment as an herbal medicine in the future.

Breast Cancer - Our first successful case study halted the progress and shrunk the tumor in six weeks with an exclusive treatment

Our ground-breaking cancer medicine formula was successfully used to treat a woman in her 50s diagnosed in a biopsy with breast cancer (BIRADS6) that had spread to the axillary lymph nodes.

Not only did the cancer growth stop, but it actually shrank in size from July to November 2021.

No other treatments were given to this patient except our own treatment.

Significantly, this progress was made just after a short period of Novel Concepts Medical treatment, and the patient exhibited no side effects and no pain.

As seen in the ultrasound reports, the tumor in the breast measured 2.3 cm as of the September 10, 2021, report and had spread to the axillary lymph nodes. Our treatment, which started in late September, has halted the progress of the cancer, as shown in the November ultrasound, and the tumor’s size has shrunk to 2.0 cm.

The blood tests for this cancer patient show significant improvement in her previous blood results – including the glucose in her blood – as can be seen in comparing her blood tests. Among the results:

Her too high glucose (103) improved to a normal level (87)
Her too high C-reactive protein (1.66) improved to a normal level (0.07)
Her cholesterol improved significantly
Her bilirubin improved
Her Vitamin D improved significantly from 82.2 to 138

The treatment was taken by the patient in the comfort of her own home, not in the hospital, in room-temperature storage. Our 100% natural ingredients left no side effects on the patient.

For the full list of changes in the patient’s blood tests results click on the links below.

Cancer

Table of Contents - Case Studies

Cancer Patients

Skin Cancer Case Study